SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 38 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,958,000 | +63.2% | 2,000,000 | +45.5% | 0.00% | – |
| Q2 2021 | $1,812,000 | +0.9% | 1,375,000 | 0.0% | 0.00% | – |
| Q1 2021 | $1,796,000 | -46.7% | 1,375,000 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $3,371,000 | +18.2% | 1,375,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,851,000 | -9.7% | 1,375,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $3,156,000 | – | 1,375,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 92,999,000 | $138,298,000 | 4.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 84,505,000 | $125,210,000 | 1.08% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,000,000 | $29,789,000 | 0.79% |
| Verition Fund Management LLC | 27,047,000 | $40,063,000 | 0.35% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,970,000 | $11,789,000 | 0.22% |
| Baker Brothers Advisors | 29,174,000 | $43,167,000 | 0.19% |
| Calamos Advisors LLC | 23,631,000 | $35,035,000 | 0.15% |
| RWC Asset Management LLP | 2,900,000 | $4,300,000 | 0.13% |
| Aequim Alternative Investments LP | 1,957,000 | $2,899,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,148,000 | $4,666,000 | 0.10% |